Within a matter of months, we’re likely to see substantial growth in the number of EP ablation procedures performed in surgery centers outside the hospital. Here’s what we can expect.
With so much supporting data and real-world success, it is time for catheter ablation to become a routine treatment option for patients suffering from arrhythmias.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Pulsed Field Ablation can be used in several different ways, but its most valuable benefits are best illustrated through catheter ablation of atrial fibrillation (AF), and it’s important for it to be put in context.
Venclose has received $27 million in Series C funding to expand market share for it venous reflux therapy. This RF ablation device is designed to simplify treatment and reduce procedure times.
The Israeli company's technology uses the power of focused ultrasound guided by MR imaging to target conditions like essential tremor, Parkinson's disease and neuropathic pain.
The HeartLight system allows electrophysiologists to control the delivery of laser energy through direct visual guidance to isolate pulmonary veins with high procedural flexibility.
3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed.
Bay Area startup Channel Medsystems' technology freezes the uterine lining to prevent excess menstrual building. It just raised $23.9 million for this device, which can be used in less than three minutes.
NeuWave's FDA-cleared technology kills tumor cells with microwave energy - helping some patients avoid surgery.
A well-funded Baltimore startup whose spray cryotechnology flash-freezes unwanted or malignant tissues inside the body just raised a touch more capital. According to a regulatory filing, CSA Medical just raised $2.9 million – on top of the $55 million it’s raised to date. Before this, CSA Medical’s most recent fundraise was a $16 million Series […]
Bay Area cryballoon ablation startup C2 Therapeutics just raised $11.6 million, according to a regulatory filing. The company’s Coldplay Focal Cryoballoon Ablation System is meant to treat Barrett’s Esophagus – a fairly asymptomatic condition in which the tissue lining the esophagus gets replaced by a different kind of tissue – the sort that is found in […]
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Securus Medical Group said today it’s got a new CEO and a new investor backing it as part of a $6.5 million Series B. According to the company, the cash, and the new leadership, will allow it to continue development of a thermographic mapping system. Its infrared-based temperature monitoring device is designed for use during […]
Two top medical device companies turned up the heat on the renal denervation competition. Both Boston Scientific (BSX) and St. Jude Medical (STJ) delivered promising results from studies on their two respective renal denervation technologies at the Transcatheter Cardiovascular Therapeutics conference in San Francisco. Such technology uses radiofrequency ablation on the nerves leading to the […]
Boston Scientific (BSX) announced it has received U.S. Food and Drug Administration approval for its IntellaTip MiFi XP catheter and 501(k) clearance for its Zurpaz 8.5F steerable sheath, growing its EP mapping/ablation technology portfolio. This makes it the third major player–following both St. Jude Medical, which acquired Endosense, and GE, which invested in Acutus Medical–to […]
The growing A-fib market continues to gain the attention of the major players this week: GE Ventures helped Acutus Medical to close a $28 million Series B round. The San Diego-based startup is working to develop a minimally invasive, real-time 3-D Cardiac Chamber Imaging and Dipole Density Mapping system. This technology could help physicians locate […]
As predicted, the next incremental advances in the growing A-fib heart space may very well be in contact force catheter technology. St. Jude’s Medical is banking on it. The company just acquired Endosense, a Switzerland company that creates contact force ablation catheter technology, for $170 million. If Endosense meets an undisclosed regulatory milestone, it could […]